Evaluation of phosphatidylinositol-3-kinase catalytic subunit (PIK3CA) and epidermal growth factor receptor (EGFR) gene mutations in pancreaticobiliary adenocarcinoma

Journal of Gastrointestinal Oncology

Anubha Bharthuar¹  Ken Lo²  Michael R. Rossi⁵  Guy A. Weiss⁴  Nikhil I. Khushalani¹  John K. Cowell³  John F. Gibbs¹  Renuka Iyer¹ 

[1] Roswell Park Cancer Inst, Buffalo, New York, USARoswell Park Cancer Inst, Buffalo, New York, USARoswell Park Cancer Inst, Buffalo, New York, USA;Epigenetics, Roche Nimblegen, Inc., Madison, Wisconsin, USAEpigenetics, Roche Nimblegen, Inc., Madison, Wisconsin, USAEpigenetics, Roche Nimblegen, Inc., Madison, Wisconsin, USA;GHSU Cancer Center, Medical College of Georgia, Georgia Health Sciences University, Augusta, Georgia, USA GHSU Cancer Center, Medical College of Georgia, Georgia Health Sciences University, Augusta, Georgia, USA GHSU Cancer Center, Medical College of Georgia, Georgia Health Sciences University, Augusta, Georgia, USA;Department of Medicine, University at Buffalo, Buffalo, New York, USADepartment of Medicine, University at Buffalo, Buffalo, New York, USADepartment of Medicine, University at Buffalo, Buffalo, New York, USA;Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia, USADepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia, USADepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia, USA

关键词: Phosphatidylinositol-3-kinase catalytic subunit (PIK3CA);    epidermal growth factor receptor (EGFR);    mutations;    pancreas;    biliary;    cancer;   

DOI  :  10.3978/j.issn.2078-6891.2012.012

学科分类：肿瘤学

来源: Pioneer Bioscience Publishing Company

【 授权许可】

Unknown